Resources Contact Us Home
S-dimethylarsino-thiosuccinic acid S-dimethylarsino-2-thiobenzoic acid S-(dimethylarsino) glutathione as treatments for cancer

Image Number 16 for United States Patent #7619000.

Arsenic trioxide, an inorganic compound, is commercially available anti-cancer agent but it carries significant toxicity. Organic arsenicals, on the other hand, are much less toxic, to the extent that the methylation of inorganic arsenic in vivo into organic arsenicals has been considered a detoxification reaction. New organic arsenic derivatives have been synthesized, including S-dimethylarsino-glutathione, S-dimethylarsino-thiosuccinic acid and S-dimethylarsino-thiobenzoic acid, and established its potent in vitro cytotoxic activity against numerous human tumor cell lines, both of solid and hematological origin, as well as against malignant blood cells from patients with leukemia. Results form a basis for the development of S-dimethylarsino-glutathione, S-dimethylarsino-thiosuccinic acid, S-dimethylarsino-thiobenzoic acid, and other organic arsenicals as an anti-cancer therapy, combining high efficacy with very low, if any, toxicity.

  Recently Added Patents
Aqueous lubricant
Methods and systems for dynamic division of path capacity
Mobile biological material energy conversion
Method of reducing cell death by administering a paracrine factor of a mesenchymal stem cell
High availability data storage systems and methods
Battery pack system
Vehicle front fascia
  Randomly Featured Patents
No-battery information storage medium capable of efficiently transmitting data
Universally adjustable vise stop
Tea processing with zeolites
Multi-purpose folding carrier
Optical amplification for the fiber interferometer gyro
Microlens manufacture
Linearly scalable geothermic fuel cells
Footwear upper
Light bar
Ceramic heater with ring member electrically connecting the heater to lead terminal core rod